Safety and effectiveness of low-dose amikacin in nontuberculous mycobacterial pulmonary disease treated in Toronto, Canada

BACKGROUND: Treatment guidelines suggest either a low-dose or high-dose approach when prescribing amikacin for nontuberculous mycobacterial pulmonary disease (NTM PD), but data supporting the low-dose approach are limited. The purpose of this study was to describe the safety and efficacy of the use...

Descripción completa

Detalles Bibliográficos
Autores principales: Aznar, Maria Luisa, Marras, Theodore K., Elshal, Ahmed Said, Mehrabi, Mahtab, Brode, Sarah K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547538/
https://www.ncbi.nlm.nih.gov/pubmed/31159865
http://dx.doi.org/10.1186/s40360-019-0302-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547538/
https://www.ncbi.nlm.nih.gov/pubmed/31159865
http://dx.doi.org/10.1186/s40360-019-0302-1

Ejemplares similares